SCHEMBL369526

SCHEMBL369526

Cn1ccc(C(=O)O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11715676 0.98 TSHR (0.42)
SCHEMBL11726606 0.83 AKR1B1 (0.42)
SCHEMBL5062781 0.79
SCHEMBL19159756 0.79
SCHEMBL11728665 0.79 AKR1B1 (0.58)
SCHEMBL12094828 0.76 MAPT (0.42)
SCHEMBL1527228 0.76 TSHR (0.48)
SCHEMBL13040083 0.76 ALDH1A1 (0.44)
SCHEMBL10110775 0.76 PGR (0.38)
SCHEMBL22518504 0.74 AOC2 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112661688-B Synthetic method of non-steroidal anti-inflammatory drug tolmetin 杭州迪克科技有限公司 2023-04-07 CN claimed
US-20210375501-A1 SELF-HEALING AND STRETCHABLE POLYMERIC COMPOSITIONS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA 2021-12-02 US claimed
EP-4029868-B1 MCL-1 INHIBITORS GILEAD SCIENCES INC (US) 2026-05-20 EP disclosed
EP-4737449-A1 P53-Y220C SELECTIVE SMALL-MOLECULAR REACTIVATOR COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2026-05-06 EP disclosed
WO-2026090477-A1 HELICASE INHIBITORS AND USES THEREOF KIMIA THERAPEUTICS, INC. (US) 2026-04-30 WO disclosed
US-12559462-B2 Pyrimidine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2026-02-24 US disclosed
US-20250270172-A1 Pyrimidine Derivatives As Modulators of the 5-HT2A Serotonin Receptor Useful For The Treatment of Disorders Related Thereto ARENA PHARMACEUTICALS, INC. (US) 2025-08-28 US disclosed
EP-4236937-B1 PYRIMIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2025-07-23 EP disclosed
CN-119923385-A Inhibitors of RNA helicase DHX9 and uses thereof 埃克森特治疗公司 2025-05-02 CN disclosed
EP-3917527-B1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC (US) 2025-04-23 EP disclosed
WO-2025049820-A1 STAT6 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2025-03-06 WO disclosed
US-5661166-A TREATING PEPTIC ULCERS TOKYO TANABE CO. LTD. (JP) 1997-08-26 US disclosed
EP-0771790-A1 Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives SUNTORY LIMITED (JP) 1997-05-07 EP disclosed
EP-0623619-A1 NEW ARENO[e]INDOLS, PREPARATION METHOD AND APPLICATION AS INTERMEDIATES IN THE SYNTHESIS OF PRODUCTS WITH ANTITUMORAL ACTIVITY PHARMA-MAR S.A.-PHARMAR (ES) 1994-11-09 EP disclosed
US-4563444-A ANTITUMOR AGENTS FARMITALIA CARLO ERBA S.P.A. (IT) 1986-01-07 US disclosed
US-4511575-A Antidiabetic pyrrolecarboxylic acids PFIZER INC. (US) 1985-04-16 US disclosed
US-4511576-A Antidiabetic pyrrolecarboxylic acids PFIZER INC. (US) 1985-04-16 US disclosed
US-4351843-A LOWERING BLOOD GLUCOSE PFIZER INC. (US) 1982-09-28 US disclosed
US-4282242-A HYPOGLYCEMIC AGENTS PFIZER INC. (US) 1981-08-04 US disclosed
US-4194003-A New pyrrole derivatives, process for their preparation and therapeutic applications thereof ALBERT ROLLAND S.A. (FR) 1980-03-18 US disclosed